Delivery Order SPE2DB22D1202-SPE2DB25FVKP2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Trumenba 120 micrograms/0.5 milliliter vaccine in 0.5 milliliter units, with a ceiling value of $1,749.30 and firm fixed pricing. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,062.52 contract is for the supply of 120 mcg/0.5 ml doses of the Trumenba vaccine, with a performance period ending on May 8, 2025. The award is not set-aside and represents an open competition. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the provision of 120 mcg/0.5 ml doses of the TRUMENBA vaccine, a total ceiling value of $2,125.04. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $1,797 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561529638 Trumenba 120 mcg/0.5 ml vaccine doses. The single day contract has a period of performance from July 18 through July 19, 2023 for product delivery to a location in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for the meningococcal vaccine Trumenba supports DLA's mission to provide...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,125.04 for TRUMENBA 120MCG (meningococcal B vaccine) on July 28, 2025, with an ultimate completion date of July 29, 2025. The contract, which was competitively awarded with no set-aside designation, utilizes firm fixed pricing and is being performed at the company's Conshohocken, PA facility. This delivery order falls under the Defense Logistics...
- The Defense Logistics Agency awarded a $4,598 delivery order to Amerisourcebergen Drug Corporation for 4561543461 TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML. The firm fixed price order is under an indefinite delivery/indefinite quantity contract vehicle to supply pharmaceutical products and services to DOD. Amerisourcebergen will deliver the specified vaccines to its Conshohocken, Pennsylvania facility by July 20, 2023 to support DLA's mission to provide medical supplies to the Armed Forces. No...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML. The contract has a ceiling value of $1,062.52 and is a Firm Fixed Price type contract. The place of performance is Conshohocken, Pennsylvania. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRUMENBA 120MCG 10S, a vaccine product. The contract has a ceiling value of $1,062.52 and a period of performance through June 30, 2025. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of Trumenba 120 mcg/0.5 ml vaccine in 0.5 ml doses. The firm-fixed-price delivery order has a ceiling value of $2,887.80 and an ultimate completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $3,594.10 to Amerisourcebergen Drug Corporation for 4561636428 TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from July 28, 2023 through July 31, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency manages the global...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVKP2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,872.68 to AmerisourceBergen Drug Corp for the supply of Trumenba 120 mcg/0.5 ml vaccine in 0.5 ml units. This non-set-aside, firm fixed-price delivery order was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a procurement of pharmaceutical products supporting the federal government's medical supply chain, specifically fulfilling vaccination needs for military and related healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract vehicle SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying an extensive range of vaccines, medications, and medical supplies across multiple therapeutic domains. The parent IDC enables the company to provide comprehensive global pharmaceutical support to military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible ordering mechanisms such as this delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/8/25 |